(lp0
(lp1
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a60 YEAR OLD FEMALE BRCA-2 CARRIER, HISTORY OF LEFT BREAST IDC (2005), NOW WITH\u000a\u000aNEW 8MM ENHANCING FOCUS IN THE RIGHT BREAST ON MRI. QUESTION BREAST CANCER.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p2
aVH
p3
aa(lp4
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a62-YEAR-OLD F WITH HISTORY LEFT BREAST DCIS NOW WITH SUSPICIOUS MRI IN THE RIGHT\u000a\u000aBREAST.  QUESTION DCIS.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p5
ag3
aa(lp6
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a62-YEAR-OLD F WITH HISTORY LEFT BREAST DCIS NOW WITH SUSPICIOUS MRI IN THE RIGHT\u000a\u000aBREAST.  QUESTION DCIS.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p7
ag3
aa(lp8
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a66 YEAR OLD FEMALE WITH GROUP OF INDETERMINATE CALCIFIATIONS IN HER RIGHT\u000a\u000aBREAST, ? FIBROADENOMA, ?DCIS. CALCS ARE IN THE ORANGE CASSETTE.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p9
ag3
aa(lp10
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a66 YEAR OLD FEMALE WITH MASS IN RIGHT BREAST AT 9 O'CLOCK.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT 9:00\u000a\u000a\u000a\u000a
p11
ag3
aa(lp12
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a68 FEMALE WITH INDETERMINATE GROUPED CALCIFICATIONS IN THE UPPER OUTER QUADRANT\u000a\u000aOF THE RIGHT BREAST BIOPSIED CALCIFICATIONS ARE PRESENT IN THE CASSETTE.? DCIS\u000a\u000aVERSUS FCC.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p13
ag3
aa(lp14
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a68 YEAR OLD FEMALE STATUS POST STEREOTACTIC CORE BIOPSY OF CALCIFICATIONS IN THE\u000a\u000aUPPER INNER QUADRANT OF THE RIGHT BREAST.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p15
ag3
aa(lp16
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a70 YEAR OLD FEMALE WITH GROUP OF CALCIFICATIONS IN THE LOWER INNER LEFT BREAST\u000a\u000aRECALLED FROM SCREENING MAMMOGRAPHY\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p17
ag3
aa(lp18
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a70 YEAR OLD FEMALE WITH SUSPICIOUS IRREGULARLY SHAPED HYPOECHOIC MASS IN THE\u000a\u000aLEFT BREAST MEASURING 1.7X0.9 CM AT 3:00, ? RADIAL SCAR VS IDC, HISTORY OF RIGHT\u000a\u000aBREAST IDC GRADE I PATH AT MGH S/P LUMPECTOMY AND RADIATION IN 2013, STARTED ON\u000a\u000aARIMEDEXIN 2013.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p19
ag3
aa(lp20
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a70 YO FEMALE WITH LEFT BREAST ARCHITECTURAL DISTORTION ON MAMMOGRAPHY AND\u000a\u000aCORRESPONDING INDETERMINATE HYPOECHOIC MASS ON ULTRASOUND.  HISTORY OF LEFT\u000a\u000aBREAST DCIS IN 1998 STATUS POST LUMPECTOMY AND RADIATION THERAPY. THE PATIENT\u000a\u000aDOES NOT REMEMBER WHERE HER SCAR IS. THIS AREA MAY BE IN THE REGION OF PRIOR\u000a\u000aSURGERY.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT 2:00\u000a\u000a\u000a\u000a
p21
ag3
aa(lp22
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a71 Y/O FEMALE WITH RIGHT BREAST CALCIFICATIONS; TARGETED CALCIFICATIONS ARE\u000a\u000aCONTAINED WITHIN ORANGE CASSETTE.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p23
ag3
aa(lp24
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a75 YEAR OLD FEMALE WITH RIGHT BREAST CALCIFICATIONS.  TARGETED CALCIFICATIONS\u000a\u000aCONTAINED IN SPECIMEN.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p25
ag3
aa(lp26
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a76 YO F WITH LEFT BREAST CALCIFICATIONS.  CALCIFICATIONS CONTAINED IN SPECIMEN\u000a\u000aIN ORANGE CARTRIDGE.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p27
ag3
aa(lp28
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a79-YEAR-OLD WITH A SOLID MASS IN THE RIGHT BREAST. QUESTION IDC.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p29
ag3
aa(lp30
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aGROUPED CALCIFICATIONS IN THE LEFT OUTER UPPER BREAST.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p31
ag3
aa(lp32
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aGROUPED CALCIFICATIONS IN THE LEFT OUTER UPPER BREAST.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p33
ag3
aa(lp34
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aHISTORY OF LEFT BREAST ADH.  NOW CORE BIOPSY OF CALCIFICATIONS AND ASYMMETRY UIQ\u000a\u000aLEFT.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p35
ag3
aa(lp36
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aINDETERMINATE LEFT BREAST CALCIFICATIONS. HISTORY OF RIGHT BREAST IDC DIAGNOSED\u000a\u000aIN 2015 STATUS POST NEOADJUVANT CHEMOTHERAPY AND MASTECTOMY IN 9/2015. RECENT\u000a\u000aSTEREOTACTIC BIOPSY OF ANOTHER GROUP OF CALCIFICATIONS IN THE LEFT BREAST\u000a\u000aDEMONSTRATED FEA.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p37
ag3
aa(lp38
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aIRREGULAR HYPOECHOIC MASS AT 3:00, 2 CM FROM THE NIPPLE IN THE LEFT BREAST\u000a\u000aMEASURING 4MM.  DIFFERENTIAL INCLUDES IDC, ILC, AND RADIAL SCAR.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT 3:00, 2 CM FROM NIPPLE\u000a\u000a\u000a\u000a
p39
ag3
aa(lp40
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aLEFT BREAST SOLID MASS - PROBABLE FIBROADENOMA.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p41
ag3
aa(lp42
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aLEFT BREAST SUSPICIOUS SOLID MASS.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p43
ag3
aa(lp44
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aLEFT BREAST:  7MM HYPOECHOIC MASS AT 6:00, 5 CM FROM THE NIPPLE.  DIFFERENTIAL\u000a\u000aINCLUDES IDC.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT 6:00, 5 CM FROM NIPPLE\u000a\u000a\u000a\u000a
p45
ag3
aa(lp46
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aPATIENT WITH REGIONAL NON MASS ENHANCEMENT IN THE RIGHT BREAST.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p47
ag3
aa(lp48
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aS/P ULTRASOUND GUIDED BIOPSY OF VAGUE HYPOECHOIC AREA IN THE RIGHT BREAST AT 12\u000a\u000aO'CLOCK, 4 CM FROM NIPPLE MEASURING 2.6 CM. ?BREAST MALIGNANCY VS. FIBROSIS VS.\u000a\u000aPASH VS. RADIAL SCAR.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p49
ag3
aa(lp50
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aS/P ULTRASOUND GUIDED BIOPSY RIGHT HYPERECHOIC MASS IN THE RIGHT BREAST AT 10\u000a\u000aO'CLOCK MEASURING 9 MM. ?FIBROADENOMA VS. CANCER.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p51
ag3
aa(lp52
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aS/P US-GUIDED BIOPSY OF LEFT BREAST MASS AT 10:00, 2CM FN MEASURING 1CM. ?\u000a\u000aBREAST MALIGNANCY VS COMPLICATED CYST.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p53
ag3
aa(lp54
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aSTATUS POST STEREOTACTIC BIOPSY OF INDETERMINATE CALCIFICATIONS IN THE LOWER\u000a\u000aINNER QUADRANT OF THE LEFT BREAST. DDX: FCC VS DCIS.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p55
ag3
aa(lp56
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aSTATUS POST STEREOTACTIC CORE BIOPSY OF ASYMMETRY IN THE SUPERIOR ASPECT OF THE\u000a\u000aRIGHT BREAST.  THE ASYMMETRY MAY BE PRESENT IN THE CASSETTE.  DDX: IDC VS BENIGN\u000a\u000aENTITY.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p57
ag3
aa(lp58
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aSTEREOTACTIC BIOPSY OF CALCIFICATIONS IN THE UPPER OUTER QUADRANT OF THE RIGHT\u000a\u000aBREAST.  THE CALCIFICATIONS ARE IN THE CASSETTE. ? DCIS VS FCC.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p59
ag3
aa(lp60
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aSTEREOTACTIC BIOPSY OF INDETERMINATE GROUPED MICROCALCIFICATIONS UPPER OUTER\u000a\u000aQUADRANT RIGHT BREAST.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p61
ag3
aa(lp62
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aSTEREOTACTIC CORE BIOPSY OF INDETERMINATE CALCIFICATIONS IN THE UPPER OUTER\u000a\u000aQUADRANT OF THE RIGHT BREAST. HISTORY OF RIGHT BREAST ADH IN 2013.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p63
ag3
aa(lp64
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aSTEREOTACTIC CORE BIOPSY OF INDETERMINATE CALCIFICATIONS IN THE UPPER OUTER\u000a\u000aQUADRANT OF THE RIGHT BREAST. HISTORY OF RIGHT BREAST ADH IN 2013.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p65
ag3
aa(lp66
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aSTEREOTACTIC CORE BIOPSY OF INDETERMINATE LEFT BREAST CALCIFICATIONS IN THE\u000a\u000aUPPER OUTER QUADRANT.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p67
ag3
aa(lp68
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aULTRASOUND GUIDED BIOPSY. RIGHT BREAST- SOFT TISSUE IN DUCT WHICH IS MILDLY\u000a\u000aDILATED; NOT HYPERVASCULAR . DDX- DUCTAL DEBRIS VS DUCTAL CARCINOMA IN-SITU.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p69
ag3
aa(lp70
VFINAL PATHOLOGIC DIAGNOSIS:\u000a\u000a\u000a\u000aA: BREAST, RIGHT AT 10:00, CORE BIOPSY:\u000a\u000aBREAST PARENCHYMA WITH FOCI OF LOBULAR NEOPLASIA (ATYPICAL LOBULAR HYPERPLASIA).\u000a\u000aPORTIONS OF LYMPHOID TISSUE CONSISTENT WITH ORIGIN FROM LYMPH NODE.\u000a\u000a\u000a\u000aNOTE: THE LOBULAR NEOPLASIA CELLS ARE NEGATIVE FOR E-CADHERIN BY\u000a\u000aIMMUNOHISTOCHEMISTRY; MULTIPLE LEVELS WERE EXAMINED (A1).\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY ELENA F BRACHTEL MD***\u000a\u000a\u000a\u000aCONSULTING PATHOLOGIST(S):\u000a\u000aELENA F BRACHTEL MD\u000a\u000a\u000a\u000aRESIDENT PATHOLOGIST:\u000a\u000aKRISTEN M BASNET MD\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a51 YO F W/ HISTORY OF MELANOMA - S/P US GUIDED CORE BX OF 3 X 5 X 4 MM OVOID\u000a\u000aHYPOECHOIC MASS RIGHT BREAST AT 10:00 - ? IM NODE VS MELANOMA VS CYST W/DEBRIS.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT 10:00\u000a\u000a\u000a\u000a
p71
ag3
aa(lp72
VFINAL PATHOLOGIC DIAGNOSIS:\u000a\u000a\u000a\u000aA: BREAST, RIGHT AT 10:00, CORE BIOPSY:\u000a\u000aBREAST PARENCHYMA WITH FOCI OF LOBULAR NEOPLASIA (ATYPICAL LOBULAR HYPERPLASIA).\u000a\u000aPORTIONS OF LYMPHOID TISSUE CONSISTENT WITH ORIGIN FROM LYMPH NODE.\u000a\u000a\u000a\u000aNOTE: THE LOBULAR NEOPLASIA CELLS ARE NEGATIVE FOR E-CADHERIN BY\u000a\u000aIMMUNOHISTOCHEMISTRY; MULTIPLE LEVELS WERE EXAMINED (A1).\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY ELENA F BRACHTEL MD***\u000a\u000a\u000a\u000aCONSULTING PATHOLOGIST(S):\u000a\u000aELENA F BRACHTEL MD\u000a\u000a\u000a\u000aRESIDENT PATHOLOGIST:\u000a\u000aKRISTEN M BASNET MD\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a51 YO F W/ HISTORY OF MELANOMA - S/P US GUIDED CORE BX OF 3 X 5 X 4 MM OVOID\u000a\u000aHYPOECHOIC MASS RIGHT BREAST AT 10:00 - ? IM NODE VS MELANOMA VS CYST W/DEBRIS.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT 10:00\u000a\u000a\u000a\u000a
p73
ag3
aa(lp74
VFINAL PATHOLOGIC DIAGNOSIS:\u000a\u000aA. BREAST CORE BIOPSY, LEFT:\u000a\u000aFRAGMENTS OF INTRADUCTAL PAPILLOMA (UP TO 0.45 CM), WITH ASSOCIATED\u000a\u000aCALCIFICATIONS.\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY AMY LY MD***\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a65 YEAR OLD FEMALE WITH LEFT BREAST CALCIFICATIONS, ? DCIS.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p75
ag3
aa(lp76
VFINAL DIAGNOSIS\u000a\u000a\u000a\u000aA.  BREAST FNA BIOPSY, LEFT:\u000a\u000a\u000a\u000aSPECIMEN ADEQUACY:\u000a\u000aEVALUATION LIMITED BY SCANT CELLULARITY.\u000a\u000a\u000a\u000aINTERPRETATION:\u000a\u000aATYPICAL\u000a\u000a\u000a\u000aDIAGNOSIS:\u000a\u000aFIBROADIPOSE TISSUE AND VERY RARE ATYPICAL CELLS.\u000a\u000a\u000a\u000a\u000a\u000aB.  BREAST CELLBLOCK, LEFT:\u000a\u000aDUCTAL ADENOCARCINOMA. SEE NOTE.\u000a\u000a\u000a\u000aNOTE: MALIGNANT CELLS COMPRISE 90% OF NUCLEATED CELLS. THERE ARE GREATER THAN 50\u000a\u000aMALIGNANT CELLS PER LEVEL. DR. BRACHTEL HAS REVIEWED THE CELL BLOCK PORTION OF\u000a\u000aTHIS CASE AND CONCURS WITH THE INTERPRETATION.\u000a\u000a\u000a\u000aTHIS CASE HAS BEEN REVIEWED BY DR. LOU VAICKUS, FELLOW IN CYTOPATHOLOGY.\u000a\u000a\u000a\u000a\u000a\u000aELECTRONICALLY SIGNED OUT BY:  WILLIAM C FAQUIN MD, PHD\u000a\u000a\u000a\u000aMARILYN NUTTER, CT(ASCP)\u000a\u000a\u000a\u000aBY HIS/HER SIGNATURE ABOVE, THE PATHOLOGIST LISTED AS MAKING THE FINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aPROCEDURES/ADDENDA\u000a\u000a\u000a\u000aRAPID INTERPRETATION\u000a\u000aORDERED DATE: 2/17/2015\u000a\u000a\u000a\u000aA. BREAST FNA BIOPSY, LEFT:\u000a\u000aFNA RAPID INTERPRETATION:\u000a\u000a\u000a\u000aSCANT ATYPICAL CELLS. AWAIT PERMANENTS.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  ELENA F BRACHTEL MD ON 2/17/2015 16:41***\u000a\u000a\u000a\u000aPATIENT EVALUATION AND MANAGEMENT (WITH INTERPRETATION)\u000a\u000aORDERED DATE: 2/17/2015\u000a\u000a\u000a\u000a\u000a\u000aCHIEF COMPLAINT: THIS 65 YEAR OLD FEMALE WAS REFERRED TO THE PATHOLOGY FINE\u000a\u000aNEEDLE ASPIRATION BIOPSY SERVICE BY MICHELLE GADD, MD FOR CONSULTATION AND\u000a\u000aDIAGNOSIS OF A LESION IN THE LEFT BREAST.\u000a\u000a\u000a\u000aCLINICAL HISTORY: 65-YEAR-OLD FEMALE WITH AN IRREGULAR, SOLID, 1.2 CM MASS WITH\u000a\u000aINDISTINCT MARGINS AT 3 O'CLOCK, 6 CM FROM THE NIPPLE.\u000a\u000a\u000a\u000aPHYSICAL EXAM:  THE LEFT BREAST SHOWED A 1.1 CM TENDER, FAIRLY ILL-DEFINED,\u000a\u000aOVOID, FIRM AND MOBILE MASS.\u000a\u000a\u000a\u000aULTRASOUND WAS USED TO EVALUATE THE LESION AND SHOWED A 1.1 X 1.0 CM LESION THAT\u000a\u000aWAS WELL-DEFINED, OVOID, SOLID, HOMOGENEOUSLY HYPOECHOIC AND WITHOUT SIGNIFICANT\u000a\u000aINTERNAL VASCULARITY.\u000a\u000a\u000a\u000aASSESSMENT:  BASED ON THE CLINICAL HISTORY AND PHYSICAL EXAMINATION, AN FNAB IS\u000a\u000aWARRANTED.\u000a\u000a\u000a\u000aPROCEDURE: THE PROCEDURE AND POTENTIAL COMPLICATIONS WERE EXPLAINED TO THE\u000a\u000aPATIENT, WHO UNDERSTOOD THE PURPOSE, RISKS, AND BENEFITS OF THE PROCEDURE.  THE\u000a\u000aPATIENT CONFIRMED NAME, DATE OF BIRTH, LATERALITY, AND LESION TO BE ASPIRATED.\u000a\u000aWRITTEN CONSENT WAS OBTAINED.\u000a\u000a\u000a\u000aTHE BIOPSY PROCEDURE WAS PERFORMED BY PALPATION.\u000a\u000a\u000a\u000a4 ASPIRATES WERE PERFORMED USING 23 GAUGE NEEDLES WITH LOCAL ANESTHESIA AND\u000a\u000aWITHOUT COMPLICATIONS.\u000a\u000a3 SLIDES WERE STAINED FOR IMMEDIATE EVALUATION. ADDITIONAL TISSUE WAS SUBMITTED\u000a\u000aFOR FURTHER EVALUATION.\u000a\u000a\u000a\u000aTHE PROCEDURE WAS PERFORMED BY: ELENA BRACHTEL, M.D. AND KRISTEN BASNET, M.D.\u000a\u000a\u000a\u000aDISPOSITION: THE IMMEDIATE INTERPRETATION FINDINGS WERE NOT DISCUSSED WITH THE\u000a\u000aPATIENT. MICHELLE GADD, MD WAS NOTIFIED OF THE PRELIMINARY RESULTS BY PHONE AT\u000a\u000a4:10 P.M.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aTHE SIGNING PATHOLOGIST ATTESTS THAT HE/SHE PERFORMED THE PROCEDURE OR, IF\u000a\u000aPERFORMED BY A RESIDENT OR FELLOW, DIRECTED AND SUPERVISED THE FNA PROCEDURE AND\u000a\u000aWAS IMMEDIATELY AVAILABLE TO FURTHER ASSIST THE RESIDENT/FELLOW BEFORE, DURING\u000a\u000aAND AFTER THE PROCEDURE, AND HAS REVIEWED AND CONFIRMED THE INTERPRETATION OF\u000a\u000aSLIDES STAINED FOR IMMEDIATE EVALUATION.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  ELENA F BRACHTEL MD ON 2/17/2015 16:46***\u000a\u000a\u000a\u000aHORMONE RECEPTOR QUANTITATION\u000a\u000aORDERED DATE: 2/23/2015\u000a\u000a\u000a\u000aB. BREAST CELLBLOCK, LEFT:\u000a\u000aBLOCK TESTED:  B1\u000a\u000aTHE TUMOR CELLS DO NOT STAIN FOR ESTROGEN RECEPTOR PROTEIN.\u000a\u000aRARE TUMOR CELLS STAIN FAINTLY FOR PROGESTERONE RECEPTOR PROTEIN.\u000a\u000aTHE TUMOR CELLS SHOW FOCAL MODERATE (2+) OVEREXPRESSION OF HER-2 PROTEIN.\u000a\u000a\u000a\u000aNOTE:\u000a\u000aESTROGEN AND PROGESTERONE RECEPTOR QUANTITATION: THE PERCENT OF IMMUNOREACTIVE\u000a\u000aNUCLEI IN THE TUMOR CELLS IS ASSESSED VISUALLY AND REPORTED AS FOLLOWS:\u000a\u000a- THE TUMOR CELLS STAIN (> 10% OF NUCLEI STAINED)\u000a\u000a- SOME TUMOR CELLS STAIN (1 TO <10% OF NUCLEI STAINED)\u000a\u000a- RARE TUMOR CELLS STAIN (< 1% OF NUCLEI STAINED)\u000a\u000a- THE TUMOR CELLS DO NOT STAIN (0% OF NUCLEI STAINED)\u000a\u000a\u000a\u000aHER-2 QUANTITATION: THE TUMOR CELLS MEMBRANE IMMUNOREACTIVITY IS EVALUATED\u000a\u000aVISUALLY AND REPORTED AS FOLLOWS:\u000a\u000a- DO NOT SHOW OVEREXPRESSION (0 TO 1+, NO/MINIMAL IMMUNOREACTIVITY OR\u000a\u000aINCOMPLETE MEMBRANE STAINING OF TUMOR CELLS)\u000a\u000a- SHOW MODERATE (2+) OVEREXPRESSION (WEAK TO MODERATE COMPLETE OR INCOMPLETE\u000a\u000aMEMBRANE IMMUNOREACTIVITY IN > 10% OF TUMOR CELLS)\u000a\u000a- SHOW STRONG (3+) OVEREXPRESSION (STRONG COMPLETE MEMBRANE IMMUNOREACTIVITY\u000a\u000aIN > 10% OF TUMOR CELLS)\u000a\u000a\u000a\u000aREFERENCE:  ASCO/CAP HER2 TESTING GUIDELINE UPDATE, ARCH PATHOL LAB MED.\u000a\u000aDOI:10.5858/ARPA.2013-0953.SA\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  ELENA F BRACHTEL MD ON 2/23/2015 16:16***\u000a\u000a\u000a\u000aHER-2 FISH QUANTITATION ANALYSIS\u000a\u000aORDERED DATE: 2/26/2015\u000a\u000a\u000a\u000aB. BREAST CELLBLOCK, LEFT:\u000a\u000aBLOCK TESTED:  B1\u000a\u000aHER-2/NEU GENE IN TUMOR CELLS: 0.9 (NOT AMPLIFIED).\u000a\u000a\u000a\u000aNOTE:  A RATIO OF GREATER THAN 2.0 OR EQUAL TO 2.0 INDICATES HER-2/NEU GENE\u000a\u000aAMPLIFICATION.\u000a\u000a\u000a\u000aRESULTS ARE EXPRESSED AS THE AVERAGE RATIO OF HER-2 SIGNALS TO CHROMOSOME 17\u000a\u000a(CEP17) SIGNALS IN 30 TUMOR CELL NUCLEI USING PATHVYSION BY HER-2 DNA PROBE KIT\u000a\u000a(ABBOTT MOLECULAR INC.). THE AVERAGE HER-2 COPY NUMBER/CELL IS 2.0 AND THE\u000a\u000aAVERAGE CEP17 COPY NUMBER/CELL IS 2.2.\u000a\u000a\u000a\u000aRESULTS NEAR THE CUTOFF POINT (HER-2/CEP17 RATIO 2.0) SHOULD BE INTERPRETED WITH\u000a\u000aCAUTION IF THE HER-2/CEP17 RATIO IS < 2 WITH THE AVERAGE HER-2 COPY NUMBER EQUAL\u000a\u000aTO OR GREATER THAN 4 AND < 6.0 SIGNALS PER CELL (EQUIVOCAL AMPLIFICATION).\u000a\u000a\u000a\u000aREFERENCE: ASCO/CAP HER2 TESTING GUIDELINE UPDATE, ARCH PATHOL LAB MED.\u000a\u000aDOI:10.5858/ARPA.2013-0953.SA\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  ELENA F BRACHTEL MD ON 2/26/2015 17:58***\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a65 YEAR OLD FEMALE WITH AN IRREGULAR SOLID MASS WITH INDISTINCT MARGINS IN THE\u000a\u000aLEFT BREAST AT 3 O'CLOCK, 6 CM FROM THE NIPPLE, MEASURING 1.2CM.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aSPECIMEN SOURCE\u000a\u000aA: BREAST FNA BIOPSY, LEFT\u000a\u000aB: BREAST CELLBLOCK, LEFT\u000a\u000a\u000a\u000a
p77
aVM
p78
aa(lp79
VFINAL DIAGNOSIS\u000a\u000a\u000a\u000aA.  BREAST FNA BIOPSY, RIGHT:\u000a\u000a\u000a\u000aSPECIMEN ADEQUACY:\u000a\u000aEVALUATION LIMITED BY SCANT CELLULARITY.\u000a\u000a\u000a\u000aINTERPRETATION:\u000a\u000aATYPICAL.\u000a\u000a\u000a\u000aDIAGNOSIS:\u000a\u000aSCANT DUCTAL CELLS WITH MILD ATYPIA AND FRAGMENTS OF FIBROADIPOSE TISSUE.\u000a\u000a\u000a\u000aNOTE: THE SMEARS ARE SOMEWHAT HYPOCELLULAR. IN TWO SLIDES, FIBROADIPOSE TISSUE\u000a\u000aPREDOMINATES. IN ONE SLIDE, THERE ARE A FEW GROUPS OF DUCTAL EPITHELIUM THAT ARE\u000a\u000aMILDLY ATYPICAL, BUT SUBOPTIMALLY PRESERVED. THESE GROUPS MAY BE APOCRINE CELLS\u000a\u000aWITH SUBOPTIMAL FIXATION. HOWEVER, THE POSSIBILITY OF A MORE SERIOUS PROCESS\u000a\u000aCANNOT BE EXCLUDED WITH CERTAINTY.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aELECTRONICALLY SIGNED OUT BY:  JOSEPH MISDRAJI MD\u000a\u000a\u000a\u000aMELISSA M. RING CT (ASCP) MBCM\u000a\u000a\u000a\u000aBY HIS/HER SIGNATURE ABOVE, THE PATHOLOGIST LISTED AS MAKING THE FINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aPROCEDURES/ADDENDA\u000a\u000a\u000a\u000aRAPID INTERPRETATION\u000a\u000aORDERED DATE: 4/9/2015\u000a\u000a\u000a\u000aA. BREAST FNA BIOPSY, RIGHT:\u000a\u000aFNA RAPID INTERPRETATION:\u000a\u000a\u000a\u000aSCANT FRAGMENTS OF FIBROADIPOSE TISSUE.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  ELENA F BRACHTEL MD ON 4/13/2015 16:14***\u000a\u000a\u000a\u000aPATIENT EVALUATION AND MANAGEMENT (WITH INTERPRETATION)\u000a\u000aORDERED DATE: 4/9/2015\u000a\u000a\u000a\u000a\u000a\u000aCHIEF COMPLAINT: THIS 56 YEAR OLD FEMALE WAS REFERRED TO THE PATHOLOGY FINE\u000a\u000aNEEDLE ASPIRATION BIOPSY SERVICE BY KRISTA ELLIOT, NP FOR CONSULTATION AND\u000a\u000aDIAGNOSIS OF A LESION IN THE RIGHT BREAST.\u000a\u000a\u000a\u000aCLINICAL HISTORY: DCIS (2005, RIGHT BREAST, LOWER INNER QUADRANT) NOW WITH RIGHT\u000a\u000aBREAST LUMP AT UPPER OUTER QUADRANT.\u000a\u000a\u000a\u000aPHYSICAL EXAM:  THE RIGHT BREAST SHOWED A 1CM NON-TENDER, ILL-DEFINED, OVOID,\u000a\u000aSOFT AND MOBILE NODULE.\u000a\u000a\u000a\u000aULTRASOUND WAS USED TO EVALUATE THE LESION, WHICH DID NOT REVEAL A DISCRETE\u000a\u000aLESION.\u000a\u000a\u000a\u000aASSESSMENT:  BASED ON THE CLINICAL HISTORY AND PHYSICAL EXAMINATION, AN FNAB IS\u000a\u000aWARRANTED.\u000a\u000a\u000a\u000aPROCEDURE: THE PROCEDURE AND POTENTIAL COMPLICATIONS WERE EXPLAINED TO THE\u000a\u000aPATIENT, WHO UNDERSTOOD THE PURPOSE, RISKS, AND BENEFITS OF THE PROCEDURE.  THE\u000a\u000aPATIENT CONFIRMED NAME, DATE OF BIRTH, LATERALITY, AND LESION TO BE ASPIRATED.\u000a\u000aWRITTEN CONSENT WAS OBTAINED.\u000a\u000a\u000a\u000aTHE BIOPSY PROCEDURE WAS PERFORMED BY PALPATION.\u000a\u000a\u000a\u000a3 ASPIRATES WERE PERFORMED USING 23 AND 25 GAUGE NEEDLES WITHOUT LOCAL\u000a\u000aANESTHESIA AND WITHOUT COMPLICATIONS.\u000a\u000a3 SLIDES WERE STAINED FOR IMMEDIATE EVALUATION. ADDITIONAL TISSUE WAS SUBMITTED\u000a\u000aFOR FURTHER EVALUATION.\u000a\u000a\u000a\u000aTHE PROCEDURE WAS PERFORMED BY: ELENA BRACHTEL, M.D. AND ERIC YANG, M.D. PH.D.\u000a\u000a\u000a\u000aDISPOSITION: THE IMMEDIATE INTERPRETATION FINDINGS WERE DISCUSSED WITH THE\u000a\u000aPATIENT. KRISTA ELLIOT, N.P WAS NOTIFIED OF THE PRELIMINARY RESULTS BY E-MAIL AT\u000a\u000a2:00 P.M.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aTHE SIGNING PATHOLOGIST ATTESTS THAT HE/SHE PERFORMED THE PROCEDURE OR, IF\u000a\u000aPERFORMED BY A RESIDENT OR FELLOW, DIRECTED AND SUPERVISED THE FNA PROCEDURE AND\u000a\u000aWAS IMMEDIATELY AVAILABLE TO FURTHER ASSIST THE RESIDENT/FELLOW BEFORE, DURING\u000a\u000aAND AFTER THE PROCEDURE, AND HAS REVIEWED AND CONFIRMED THE INTERPRETATION OF\u000a\u000aSLIDES STAINED FOR IMMEDIATE EVALUATION.\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  ELENA F BRACHTEL MD ON 4/13/2015 16:16***\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aNODULE RIGHT BREAST.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aSPECIMEN SOURCE\u000a\u000aA: BREAST FNA BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p80
ag78
aa(lp81
VFINAL DIAGNOSIS\u000a\u000a\u000a\u000aA.  BREAST FNA BIOPSY, RIGHT:\u000a\u000a\u000a\u000aSPECIMEN ADEQUACY:\u000a\u000aEVALUATION LIMITED BY SCANT CELLULARITY.\u000a\u000a\u000a\u000aINTERPRETATION:\u000a\u000aSUSPICIOUS FOR MALIGNANCY.\u000a\u000a\u000a\u000aDIAGNOSIS:\u000a\u000aVERY SCANT MATERIAL CONSISTING OF SLIGHTLY DYSHESIVE EPITHELIOID CELLS WITH\u000a\u000aNUCLEAR ATYPICALITY, SUSPICIOUS FOR BUT NOT DIAGNOSTIC OF MAMMARY CARCINOMA.\u000a\u000a\u000a\u000a\u000a\u000aB.  BREAST CELLBLOCK, RIGHT:\u000a\u000aRARE ATYPICAL EPITHELIOID CELLS, SUSPICIOUS FOR BUT NOT DIAGNOSTIC OF MAMMARY\u000a\u000aCARCINOMA.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aELECTRONICALLY SIGNED OUT BY:  JOSEPH MISDRAJI MD\u000a\u000a\u000a\u000aPETER BROWN, CT(ASCP)\u000a\u000a\u000a\u000aBY HIS/HER SIGNATURE ABOVE, THE PATHOLOGIST LISTED AS MAKING THE FINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aPROCEDURES/ADDENDA\u000a\u000a\u000a\u000aRAPID INTERPRETATION\u000a\u000aORDERED DATE: 12/23/2014\u000a\u000a\u000a\u000aA. BREAST FNA BIOPSY, RIGHT:\u000a\u000aFNA RAPID INTERPRETATION:\u000a\u000a\u000a\u000aFEW CLUSTERS OF CROWDED EPITHELIAL CELLS, POSSIBLY WITH MYOEPITHELIAL CELLS.\u000a\u000aAWAIT REVIEW OF ALL MATERIAL FOR FINAL DIAGNOSIS\u000a\u000a\u000a\u000aCYTOTECHNOLOGIST:          PETER BROWN, CT(ASCP)\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  ROSEMARY H TAMBOURET MD ON 12/24/2014 10:07***\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a69 YEAR OLD FEMALE WITH PALPABLE SPICULATED MASS IN RIGHT UPPER OUTER BREAST,\u000a\u000aHIGHLY SUSPICIOUS FOR MALIGNANCY. ? IDC VS ILC. PATIENT ON ANTI-COAGULATION\u000a\u000aTHERAPY, CANNOT DO CORE BIOPSY.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aSPECIMEN SOURCE\u000a\u000aA: BREAST FNA BIOPSY, RIGHT\u000a\u000aB: BREAST CELLBLOCK, RIGHT\u000a\u000a\u000a\u000a
p82
ag78
aa(lp83
VFINAL DIAGNOSIS\u000a\u000a\u000a\u000aA.  BREAST FNA BIOPSY, RIGHT:\u000a\u000a\u000a\u000aSPECIMEN ADEQUACY:\u000a\u000aSATISFACTORY FOR EVALUATION.\u000a\u000a\u000a\u000aINTERPRETATION:\u000a\u000aATYPICAL.\u000a\u000a\u000a\u000aDIAGNOSIS:\u000a\u000aRARE CLUSTERS OF ATYPICAL DUCTAL CELLS ADMIXED WITH ADIPOSE AND FIBROUS TISSUE.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aELECTRONICALLY SIGNED OUT BY:  MARTHA BISHOP PITMAN MD\u000a\u000a\u000a\u000aDANIELLE TETREAULT, CT(ASCP)\u000a\u000a\u000a\u000aBY HIS/HER SIGNATURE ABOVE, THE PATHOLOGIST LISTED AS MAKING THE FINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aPROCEDURES/ADDENDA\u000a\u000aRAPID INTERPRETATION\u000a\u000a\u000a\u000aA. BREAST FNA BIOPSY, RIGHT:\u000a\u000aFNA RAPID INTERPRETATION:\u000a\u000a\u000a\u000aPREDOMINANTLY FAT AND FIBROUS TISSUE.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  AMY LY MD ON 7/24/2013 10:27***\u000a\u000aPATIENT EVALUATION AND MANAGEMENT (WITH INTERPRETATION)\u000a\u000a\u000a\u000aCHIEF COMPLAINT: THIS 73 YEAR-OLD FEMALE WAS REFERRED TO THE FINE NEEDLE\u000a\u000aASPIRATION CLINIC BY DR. S. COOPEY FOR CONSULTATION AND DIAGNOSIS OF A RIGHT\u000a\u000aBREAST MASS.\u000a\u000a\u000a\u000aCLINICAL HISTORY:  73 YEAR OLD FEMALE WITH FOCAL ASYMMETRY IN RIGHT BREAST.\u000a\u000a\u000a\u000aREVIEW OF SYMPTOMS:\u000a\u000aCONSTITUTIONAL: WELL-DEVELOPED, WELL-NOURISHED ADULT IN NO APPARENT DISTRESS.\u000a\u000aOTHER: REVIEW OF SYMPTOMS INCLUDES: FEELS WELL.\u000a\u000aALLERGY TO LIDOCAINE: NO.\u000a\u000aMEDICATIONS/ANTICOAGULANTS: PATIENT IS NOT ON BLOOD THINNERS.\u000a\u000a\u000a\u000aSOCIAL HISTORY:\u000a\u000aTOBACCO USE: NO.\u000a\u000aALCOHOL USE: NO.\u000a\u000a\u000a\u000aFAMILY HISTORY:\u000a\u000aFAMILY HISTORY OF BREAST CANCER: NO.\u000a\u000a\u000a\u000aPAST MEDICAL HISTORY:\u000a\u000aNO PERSONAL HISTORY OF MALIGNANCY.\u000a\u000a\u000a\u000aREVIEW OF PATIENT DATA IN THE EMR:\u000a\u000aRADIOLOGY: YES.\u000a\u000aPAST HISTOLOGY: NO.\u000a\u000aOFFICE NOTES: YES.\u000a\u000a\u000a\u000aPHYSICAL EXAMINATION: LATERALITY WAS ESTABLISHED ACCORDING TO DEPARTMENTAL\u000a\u000aUNIVERSAL PROTOCOL. EXAMINATION OF THE RIGHT BREAST REVEALS A 1.5 CM\u000a\u000aWELL-DEFINED, SOFT, MOBILE MASS AT 1:00, 3-4 CM FROM THE NIPPLE.  RIGHT AXILLA\u000a\u000aSHOWS A PALPABLE LYMPH NODE, MOBILE, APPROXIMATELY 0.6 CM IN SIZE.\u000a\u000a\u000a\u000aASSESSMENT: BASED ON THE CLINICAL HISTORY AND PHYSICAL EXAMINATION, AN FNAB IS\u000a\u000aWARRANTED.\u000a\u000a\u000a\u000aPROCEDURE: THE PROCEDURE AND COMPLICATIONS WERE EXPLAINED TO THE PATIENT AND\u000a\u000aWRITTEN CONSENT WAS OBTAINED.  ULTRASOUND WAS NOT USED IN THIS PROCEDURE.  3\u000a\u000aASPIRATES WERE PERFORMED USING 25 GAUGE NEEDLES WITH ANESTHESIA AND WITHOUT\u000a\u000aCOMPLICATIONS. 7 SLIDES WERE STAINED FOR IMMEDIATE EVALUATION; ADDITIONAL TISSUE\u000a\u000aWAS SUBMITTED FOR FURTHER EVALUATION.\u000a\u000a\u000a\u000aDISPOSITION:  THE IMMEDIATE INTERPRETATION FINDINGS WERE DISCUSSED WITH THE\u000a\u000aPATIENT. THE PRELIMINARY RESULTS WERE COMMUNICATED TO DR. COOPEY BY EMAIL AT\u000a\u000a4:20 P.M\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aTHE SIGNING PATHOLOGIST ATTESTS THAT HE/SHE PERFORMED THE PROCEDURE OR, IF\u000a\u000aPERFORMED BY A RESIDENT OR FELLOW, DIRECTED AND SUPERVISED THE FNA PROCEDURE AND\u000a\u000aWAS IMMEDIATELY AVAILABLE TO FURTHER ASSIST THE RESIDENT/FELLOW BEFORE, DURING\u000a\u000aAND AFTER THE PROCEDURE, AND HAS REVIEWED AND CONFIRMED THE INTERPRETATION OF\u000a\u000aSLIDES STAINED FOR IMMEDIATE EVALUATION.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  AMY LY MD ON 7/26/2013 15:27***\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a74 YEAR-OLD FEMALE WITH FOCAL ASYMMETRY OF THE RIGHT BREAST, UPPER INNER\u000a\u000aQUADRANT.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aSPECIMEN SOURCE\u000a\u000aA: BREAST FNA BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p84
ag78
aa(lp85
VFINAL DIAGNOSIS\u000a\u000a\u000a\u000aA.  BREAST FNA BIOPSY, RIGHT:\u000a\u000a\u000a\u000aSPECIMEN ADEQUACY:\u000a\u000aSATISFACTORY FOR EVALUATION.\u000a\u000a\u000a\u000aINTERPRETATION:\u000a\u000aATYPICAL.\u000a\u000a\u000a\u000aDIAGNOSIS:\u000a\u000aSCANT GROUPS OF DUCTAL CELLS WITH ATYPIA AND ASSOCIATED MYOEPITHELIAL CELLS.\u000a\u000aSINGLE CELLS SHOWING APOCRINE METAPLASIA.\u000a\u000a\u000a\u000aB.  BREAST CELLBLOCK, RIGHT:\u000a\u000aFEW ABNORMAL EPITHELIAL CELLS, SUSPECT CARCINOMA.\u000a\u000a\u000a\u000a\u000a\u000aELECTRONICALLY SIGNED OUT BY:  ROSEMARY H TAMBOURET MD\u000a\u000a\u000a\u000aDANIELLE TETREAULT, CT(ASCP)\u000a\u000a\u000a\u000aBY HIS/HER SIGNATURE ABOVE, THE PATHOLOGIST LISTED AS MAKING THE FINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aPROCEDURES/ADDENDA\u000a\u000aRAPID INTERPRETATION\u000a\u000a\u000a\u000aA. BREAST FNA BIOPSY, RIGHT:\u000a\u000aFNA RAPID INTERPRETATION:\u000a\u000a\u000a\u000aFEW ATYPICAL DUCTAL CELLS AND APOCRINE METAPLASTIC CELLS.  DEFER TO\u000a\u000aALCOHOL-FIXED SLIDES.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  KENAN J SAUDER MD ON 6/25/2013 18:21***\u000a\u000aPATIENT EVALUATION AND MANAGEMENT (WITH INTERPRETATION)\u000a\u000a\u000a\u000aCHIEF COMPLAINT: THIS 80 YEAR-OLD FEMALE WAS REFERRED TO THE FINE NEEDLE\u000a\u000aASPIRATION CLINIC BY DR. HUGHES FOR CONSULTATION AND DIAGNOSIS OF A MASS IN THE\u000a\u000aRIGHT BREAST.\u000a\u000a\u000a\u000aCLINICAL HISTORY:  MASS FOUND IN RIGHT BREAST ON ROUTINE MAMMOGRAM.\u000a\u000a\u000a\u000aREVIEW OF SYMPTOMS:\u000a\u000aCONSTITUTIONAL: WELL-DEVELOPED, WELL-NOURISHED ADULT IN NO APPARENT DISTRESS.\u000a\u000aOTHER: REVIEW OF SYMPTOMS INCLUDES: FEELS WELL.\u000a\u000aALLERGY TO LIDOCAINE: NO.\u000a\u000aMEDICATIONS/ANTICOAGULANTS: PATIENT IS ON COUMADIN.\u000a\u000a\u000a\u000aPAST MEDICAL HISTORY:\u000a\u000aPERSONAL HISTORY OF MALIGNANCY INCLUDES:\u000a\u000aBASAL CELL CARCINOMA, FACE.\u000a\u000a\u000a\u000aREVIEW OF PATIENT DATA IN THE EMR:\u000a\u000aRADIOLOGY: YES. MAMMOGRAM AND ULTRASOUND 6/24/13 IRREGULAR MASS IN LOWER OUTER\u000a\u000aQUADRANT 3 CM.\u000a\u000aPAST HISTOLOGY: YES.\u000a\u000aOFFICE NOTES: YES. DR. WU 1/24/13 MEDICAL HISTORY\u000a\u000a\u000a\u000aPHYSICAL EXAMINATION: LATERALITY WAS ESTABLISHED ACCORDING TO DEPARTMENTAL\u000a\u000aUNIVERSAL PROTOCOL. EXAMINATION OF THE RIGHT BREAST REVEALED A 3.0 X 1.8 X 1.1\u000a\u000aCM OVOID FIRM MASS, MOBILE IN THE LOWER OUTER QUADRANT.\u000a\u000a\u000a\u000aASSESSMENT: BASED ON THE CLINICAL HISTORY AND PHYSICAL EXAMINATION, AN FNAB IS\u000a\u000aWARRANTED.\u000a\u000a\u000a\u000aPROCEDURE: THE PROCEDURE AND COMPLICATIONS WERE EXPLAINED TO THE PATIENT AND\u000a\u000aVERBAL CONSENT WAS OBTAINED.  5 ASPIRATES WERE PERFORMED USING 23 AND 25 GAUGE\u000a\u000aNEEDLES WITH ANESTHESIA AND WITHOUT COMPLICATIONS. 4 SLIDES WERE STAINED FOR\u000a\u000aIMMEDIATE EVALUATION; ADDITIONAL TISSUE WAS SUBMITTED FOR FURTHER EVALUATION.\u000a\u000a\u000a\u000aDISPOSITION:  THE IMMEDIATE INTERPRETATION FINDINGS WERE NOT DISCUSSED WITH THE\u000a\u000aPATIENT. THE PRELIMINARY RESULTS WERE COMMUNICATED TO DR. HUGHES IN PERSON AT 4\u000a\u000aO'CLOCK P.M.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aTHE SIGNING PATHOLOGIST ATTESTS THAT HE/SHE PERFORMED THE PROCEDURE OR, IF\u000a\u000aPERFORMED BY A RESIDENT OR FELLOW, DIRECTED AND SUPERVISED THE FNA PROCEDURE AND\u000a\u000aWAS IMMEDIATELY AVAILABLE TO FURTHER ASSIST THE RESIDENT/FELLOW BEFORE, DURING\u000a\u000aAND AFTER THE PROCEDURE, AND HAS REVIEWED AND CONFIRMED THE INTERPRETATION OF\u000a\u000aSLIDES STAINED FOR IMMEDIATE EVALUATION.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  KENAN J SAUDER MD ON 6/25/2013 18:21***\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aRIGHT BREAST IMAGING ABNORMALITY, 3.0CM AT 7 O'CLOCK.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aSPECIMEN SOURCE\u000a\u000aA: BREAST FNA BIOPSY, RIGHT\u000a\u000aB: BREAST CELLBLOCK, RIGHT\u000a\u000a\u000a\u000a
p86
ag78
aa(lp87
VFINAL DIAGNOSIS\u000a\u000a\u000a\u000aA.  BREAST FNA BIOPSY, RIGHT:\u000a\u000a\u000a\u000aSPECIMEN ADEQUACY:\u000a\u000aSATISFACTORY FOR EVALUATION.\u000a\u000aEVALUATION LIMITED BY SCANT CELLULARITY.\u000a\u000a\u000a\u000aINTERPRETATION:\u000a\u000aATYPICAL.\u000a\u000a\u000a\u000aDIAGNOSIS:\u000a\u000aDUCTAL CELLS, ISOLATED AND IN GROUPS, WITH MILD CYTOLOGIC ATYPIA.\u000a\u000aGROUPS OF CELLS SHOW THE PRESENCE OF MYOEPITHELIUM.\u000a\u000aTHERE ARE ONLY A LIMITED NUMBER OF CELLS FOR EVALUATION.\u000a\u000a\u000a\u000aNOTE: THE FINDINGS ARE NOT DIAGNOSTIC OF MALIGNANCY.  IF THERE REMAINS CLINICAL\u000a\u000aSUSPICION OF MALIGNANCY, OBTAINING ADDITIONAL BIOPSY TISSUE IS RECOMMENDED.\u000a\u000a\u000a\u000a\u000a\u000aB.  BREAST CELLBLOCK, RIGHT:\u000a\u000aSCANT NUMBERS OF BENIGN-APPEARING DUCTAL CELLS.\u000a\u000aINSUFFICIENT FOR FURTHER DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aELECTRONICALLY SIGNED OUT BY:  DAVID CURTIS WILBUR MD\u000a\u000a\u000a\u000aDIANE KUEBLER, CT(ASCP)\u000a\u000a\u000a\u000aBY HIS/HER SIGNATURE ABOVE, THE PATHOLOGIST LISTED AS MAKING THE FINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aPROCEDURES/ADDENDA\u000a\u000a\u000a\u000aRAPID INTERPRETATION\u000a\u000aORDERED DATE: 10/27/2014\u000a\u000a\u000a\u000aA. BREAST FNA BIOPSY, RIGHT:\u000a\u000aFNA RAPID INTERPRETATION:\u000a\u000a\u000a\u000a\u000a\u000aSINGLE DUCTAL CELLS CONSISTENT WITH DUCTAL CARCINOMA\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  ROSEMARY H TAMBOURET MD ON 10/27/2014 15:36***\u000a\u000a\u000a\u000aPATIENT EVALUATION AND MANAGEMENT (WITH INTERPRETATION)\u000a\u000aORDERED DATE: 10/28/2014\u000a\u000a\u000a\u000a\u000a\u000aCHIEF COMPLAINT: THIS 69 YEAR OLD FEMALE WAS REFERRED TO THE PATHOLOGY FINE\u000a\u000aNEEDLE ASPIRATION BIOPSY SERVICE BY KEVIN HUGHES, MD FOR CONSULTATION AND\u000a\u000aDIAGNOSIS OF A LESION IN THE RIGHT BREAST MASS.\u000a\u000a\u000a\u000aCLINICAL HISTORY: MASS IN RIGHT BREAST DISCOVERED 3 WEEKS AGO BY PRIMARY CARE\u000a\u000aPHYSICIAN.\u000a\u000a\u000a\u000aPHYSICAL EXAM:  THE RIGHT BREAST SHOWED A 1.5 CM NON-TENDER, ILL-DEFINED,\u000a\u000aIRREGULAR, FIRM AND MOBILE MASS.\u000a\u000a\u000a\u000aULTRASOUND WAS USED TO EVALUATE THE LESION AND SHOWED A 1.7 X 1.8 CM LESION THAT\u000a\u000aWAS ILL-DEFINED, ROUND SOLID, HETEROGENEOUSLY HYPOECHOIC AND WITHOUT SIGNIFICANT\u000a\u000aINTERNAL VASCULARITY.\u000a\u000a\u000a\u000aASSESSMENT:  BASED ON THE CLINICAL HISTORY AND PHYSICAL EXAMINATION, AN FNAB IS\u000a\u000aWARRANTED.\u000a\u000a\u000a\u000aPROCEDURE: THE PROCEDURE AND POTENTIAL COMPLICATIONS WERE EXPLAINED TO THE\u000a\u000aPATIENT, WHO UNDERSTOOD THE PURPOSE, RISKS, AND BENEFITS OF THE PROCEDURE.  THE\u000a\u000aPATIENT CONFIRMED NAME, DATE OF BIRTH, LATERALITY, AND LESION TO BE ASPIRATED.\u000a\u000aWRITTEN CONSENT WAS OBTAINED.\u000a\u000a\u000a\u000aTHE BIOPSY PROCEDURE WAS PERFORMED BY PALPATION.\u000a\u000a\u000a\u000a2 ASPIRATES WERE PERFORMED USING 23 AND 25 GAUGE NEEDLES WITHOUT LOCAL\u000a\u000aANESTHESIA AND WITHOUT COMPLICATIONS.\u000a\u000aSLIDES WERE STAINED FOR IMMEDIATE EVALUATION. ADDITIONAL TISSUE WAS SUBMITTED\u000a\u000aFOR FURTHER EVALUATION.\u000a\u000a\u000a\u000aTHE PROCEDURE WAS PERFORMED BY: ROSEMARY TAMBOURET, M.D.\u000a\u000a\u000a\u000aDISPOSITION: THE IMMEDIATE INTERPRETATION FINDINGS WERE NOT DISCUSSED WITH THE\u000a\u000aPATIENT. KEVIN HUGHES, MD WAS NOTIFIED OF THE PRELIMINARY RESULTS BY PERSONAL\u000a\u000aCOMMUNICATION AT 1:00 P.M.\u000a\u000a\u000a\u000a\u000a\u000aTHE SIGNING PATHOLOGIST ATTESTS THAT HE/SHE PERFORMED THE PROCEDURE OR, IF\u000a\u000aPERFORMED BY A RESIDENT OR FELLOW, DIRECTED AND SUPERVISED THE FNA PROCEDURE AND\u000a\u000aWAS IMMEDIATELY AVAILABLE TO FURTHER ASSIST THE RESIDENT/FELLOW BEFORE, DURING\u000a\u000aAND AFTER THE PROCEDURE, AND HAS REVIEWED AND CONFIRMED THE INTERPRETATION OF\u000a\u000aSLIDES STAINED FOR IMMEDIATE EVALUATION.\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  ROSEMARY H TAMBOURET MD ON 10/31/2014 10:10***\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aPRIMARY CARE PHYSICIAN DISCOVERED LUMP IN RIGHT BREAST AT 7:00\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000aSPECIMEN SOURCE\u000a\u000aA: BREAST FNA BIOPSY, RIGHT\u000a\u000aB: BREAST CELLBLOCK, RIGHT\u000a\u000a\u000a\u000a
p88
ag78
aa(lp89
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a2 CM BREAST MASS.  2 O'CLOCK, 5 CM FROM NIPPLE.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: LEFT BREAST CORE BIOPSY (S14-10121-1-7; 5/20/2014)\u000a\u000a\u000a\u000aSLIDE-BLOCK DESCRIPTION:\u000a\u000aCONSULT MATERIALS RECEIVED FROM NORTH SHORE CENTER FOR OUTPATIENT CARE, DANVERS,\u000a\u000aMA\u000a\u000a\u000a\u000aA. LEFT BREAST CORE BIOPSY (S14-10121-A1; 5/20/2014):\u000a\u000aSTAINED SLIDES: 7      UNSTAINED SLIDES: 0     BLOCKS: 0\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a
p90
ag78
aa(lp91
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a2 CM BREAST MASS.  2 O'CLOCK, 5 CM FROM NIPPLE.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: LEFT BREAST CORE BIOPSY (S14-10121-1-7; 5/20/2014)\u000a\u000a\u000a\u000aSLIDE-BLOCK DESCRIPTION:\u000a\u000aCONSULT MATERIALS RECEIVED FROM NORTH SHORE CENTER FOR OUTPATIENT CARE, DANVERS,\u000a\u000aMA\u000a\u000a\u000a\u000aA. LEFT BREAST CORE BIOPSY (S14-10121-A1; 5/20/2014):\u000a\u000aSTAINED SLIDES: 7      UNSTAINED SLIDES: 0     BLOCKS: 0\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a
p92
ag78
aa(lp93
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a36 YO FEMALE WITH 2 HYPOECHOIC MASSES IN THE LEFT BREAST.  PATIENT HAS\u000a\u000aBIOPSY-PROVEN DCIS IN THE LEFT BREAST.  1. MASS AT 2:00 3 CM FN.  2. MASS AT\u000a\u000a1:00.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT 2:00\u000a\u000aB: BREAST CORE BIOPSY, LEFT 1:00\u000a\u000a\u000a\u000a
p94
ag78
aa(lp95
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a43 YEAR OLD FEMALE  STATUS POST STEREOTACTIC CORE BIOPSY OF CALCIFICATION ?\u000a\u000aBREAST CA UOQ RIGHT BREAST.  CONSIDER DUCTAL CARCINOMA IN SITU VERSUS OTHER.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p96
ag78
aa(lp97
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a43 YEAR OLD FEMALE WITH BIOPSY-PROVEN LEFT BREAST INVASIVE DUCTAL CARCINOMA,\u000a\u000aFOUND TO HAVE A 3RD FOCUS OF ENHANCEMENT IN THE RIGHT SLIGHTLY INNER, SLIGHTLY\u000a\u000aCENTRAL, POSTERIOR BREAST THAT SHOWED WASHOUT KINETICS.  CONSIDER INVASIVE\u000a\u000aDUCTAL CARCINOMA VERSUS OTHER.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p98
ag78
aa(lp99
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a43 YEAR OLD FEMALE WITH CURRENT DIAGNOSIS OF RIGHT BREAST DCIS WITH 2 ADDITIONAL\u000a\u000aENHANCING AREAS NOTED ON OUTSIDE MRI, STATUS POST MRI GUIDED BIOPSY X 2.  A.\u000a\u000aLOWER BREAST (LOWER OUTER) RIM-ENHANCING MASS.  B.  SUPERIOR BREAST (UPPER\u000a\u000aOUTER) FOCAL NON-MASS-LIKE ENHANCEMENT, ? BENIGN PROLIFERATIVE CHANGE VERSUS\u000a\u000aDCIS.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT LOWER\u000a\u000aB: BREAST CORE BIOPSY, RIGHT SUPERIOR\u000a\u000a\u000a\u000a
p100
ag78
aa(lp101
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a44 YEAR OLD WITH PRIOR HISTORY OF FEA, LCIS BILATERALLY, WITH NEW CALCIFICATIONS\u000a\u000aIN BOTH BREASTS.  STATUS POST BILATERAL BIOPSIES:\u000a\u000aRIGHT - POSTERIOR UPPER OUTER BREAST ? BENIGN VS. OTHER.\u000a\u000aLEFT - 9 O'CLOCK ? BENIGN VS. OTHER.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000aB: BREAST CORE BIOPSY AT 9:00, LEFT\u000a\u000a\u000a\u000a
p102
ag78
aa(lp103
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a45 YEAR OLD FEMALE WITH KNOWN DIAGNOSIS OF LEFT BREAST MALIGNANCY IN THE UPPER\u000a\u000aOUTER POSTERIOR LEFT BREAST, PRESENTS FOR STEREOTACTIC BIOPSY OF CALCIFICATIONS\u000a\u000aIN THE ANTERIOR INFERIOR LATERAL LEFT BREAST.  ? DUCTAL CARCINOMA IN SITU VERSUS\u000a\u000aINVASIVE DUCTAL CARCINOMA VERSUS OTHER.  CALCIFICATIONS ARE PRESENT IN THE\u000a\u000aSPECIMEN.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p104
ag78
aa(lp105
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a45 YEAR-OLD FEMALE WITH A CLUSTER OF CALCIFICATIONS IN THE UPPER OUTER RIGHT\u000a\u000aBREAST.  THE CALCIFICATIONS ARE IN THE CASSETTE.  ? DUCTAL CARCINOMA IN-SITU\u000a\u000aVERSUS INVOLUTING FIBROADENOMA.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p106
ag78
aa(lp107
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a46 YEAR OLD FEMALE WITH A CLUSTER OF CALCIFICATIONS IN THE LEFT BREAST.  ?\u000a\u000aFIBROCYSTIC CHANGE VERSUS SCLEROSING ADENOSIS VERSUS OTHER.  CALCIFICATIONS ARE\u000a\u000aIN THE CASSETTE.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p108
ag78
aa(lp109
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a46 YEAR OLD FEMALE WITH RECENTLY DIAGNOSED LEFT BREAST CANCER NOW STATUS POST\u000a\u000aSTEREOTACTIC CORE BIOPSY OF LEFT CALCIFICATIONS.  ? DCIS.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p110
ag78
aa(lp111
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a47 YEAR OLD FEMALE WITH HISTORY OF HODGKIN'S LYMPHOMA TREATED IN 1995 WITH CHEMO\u000a\u000aAND CHEST RADIATION.  WITH 2 ENLARGING ENHANCING FOCI SEEN ON MR IN THE RIGHT\u000a\u000aBREAST.  A.  POSTERIOR FOCUS-LYMPH NODE VERSUS FIBROADENOMA VERSUS OTHER.  B.\u000a\u000aANTERIOR FOCUS-? LYMPH NODE VERSUS OTHER.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT POSTERIOR\u000a\u000aB: BREAST CORE BIOPSY, RIGHT ANTERIOR\u000a\u000a\u000a\u000a
p112
ag78
aa(lp113
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a48 YEAR OLD FEMALE WITH A HISTORY OF IDC OF THE LEFT BREAST IN 2002, STATUS POST\u000a\u000aLUMPECTOMY, CHEMOTHERAPY, AND XRT NOW WITH RECURRENT IDC IN THE LEFT BREAST\u000a\u000a(2/2014) WITH RIGHT AXILLARY LYMPH NODE METASTASIS AND SUSPICIOUS CALCIFICATIONS\u000a\u000aIN THE RIGHT BREAST. ? DCIS VS FCC. TARGETED CALCIFICATIONS IN X-RAYED SPECIMENS\u000a\u000aA AND B.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT, MEDIAL\u000a\u000aB: BREAST CORE BIOPSY, RIGHT, LATERAL\u000a\u000a\u000a\u000a
p114
ag78
aa(lp115
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a48 YEAR OLD FEMALE WITH CALCIFICATIONS IN LOWER INNER RIGHT BREAST, ? FCC VS.\u000a\u000aCALCIUM OXALATE VS. DCIS.  TARGETED CALCIFICATIONS ARE IN THE SPECIMEN.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p116
ag78
aa(lp117
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a49 Y/O FEMALE WITH CLUSTER OF LEFT BREAST CALCIFICATIONS. ?SCLEROSING ADENOSIS\u000a\u000aVS MILK OF CALCIUM VS DCIS.  THE TARGETED CALCIFICATIONS ARE PRESENT IN THE\u000a\u000aSPECIMEN TRAY.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p118
ag78
aa(lp119
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a49 YEAR OLD WITH INDETERMINATE CALCIFICATIONS IN THE UPPER OUTER QUADRANT OF THE\u000a\u000aLEFT BREAST.   THE BIOPSIED CALCIFICATIONS ARE PRESENT IN THE CASSETTE.  ?\u000a\u000aSCLEROSING ADENOSIS VS. DCIS VS. FIBROCYSTIC CHANGES.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST, LEFT, CORE BIOPSY\u000a\u000a\u000a\u000a
p120
ag78
aa(lp121
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a50 YEAR OLD WOMAN WITH LEFT BREAST CALCIFICATION. (INNER LOWER LEFT BREAST) THE\u000a\u000aCALCIFICATIONS ARE IN THE CASSETTE. ? DCIS VS. OTHER.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT LOWER INNER\u000a\u000a\u000a\u000a
p122
ag78
aa(lp123
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a54 YEAR OLD FEMALE WITH HYPOECHOIC MASS IN THE RIGHT BREAST. ? FA VS OTHER.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p124
ag78
aa(lp125
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a54 YEAR OLD FEMALE WITH INDETERMINATE CALCIFICATIONS IN THE LEFT BREAST.  ?FCC\u000a\u000aVERSUS SCLEROSING ADENOSIS.  THE CALCIFICATIONS ARE IN THE SPECIMEN.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p126
ag78
aa(lp127
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a54 YEAR OLD WOMAN WITH CLUSTERED CALCIFICATIONS IN THE UPPER, SLIGHTLY INNER\u000a\u000aLEFT BREAST.  DIFFERENTIAL FIBROCYSTIC CHANGE VERSUS DCIS.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p128
ag78
aa(lp129
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a55 YEAR OLD FEMALE FOUND TO HAVE ARCHITECTURAL DISTORTION ON LEFT BREAST\u000a\u000aMAMMOGRAM. HYPOECHOIC MASS FOUND ON ULTRASOUND IN LEFT BREAST 9 O'CLOCK, 4 CM\u000a\u000aFROM NIPPLE MEASURING 8 X 7 X 7 MM. CONSIDER RADIAL SCAR VS IDC VS OTHER.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p130
ag78
aa(lp131
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a55 YO F W/ INDETERMINANT CALCIFICATIONS IN THE LEFT BREAST. PT HAS A KNOWN\u000a\u000aBREAST CA IN RIGHT BREAST. ? CALCIUM OXALATE VS DCIS. X-RAYED CALCIFICATIONS ARE\u000a\u000aNOT PRESENT.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p132
ag78
aa(lp133
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a58 YO OF WITH LEFT SUBAREOLAR BREAST CANCER AND LEFT 12 O'CLOCK CALCIFICATIONS.\u000a\u000aTARGETED CALCIFICATIONS ARE IN SPECIMEN ? FIBROCYSTIC CHANGES VS SCLEROSING\u000a\u000aADENOSIS VS DCIS.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p134
ag78
aa(lp135
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a59 Y.O. F W/ KNOW BX PROVEN IDC IN THE LEFT BREAST PRESENTS FOR US BIOPSY OF TWO\u000a\u000aHYPOECHOIC MASSES IN THE LEFT BREAST. 4:00 ? IDC. 2:00 ? FCC VS IDC.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT 4:00\u000a\u000aB: BREAST CORE BIOPSY, LEFT 2:00\u000a\u000a\u000a\u000a
p136
ag78
aa(lp137
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a59 YEAR OLD FEMALE, PRESENTED FROM OUTSIDE HOSPITAL WITH LEFT BREAST ASYMMETRY\u000a\u000aON MAMMOGRAM.  MASS FOUND IN THE LEFT BREAST ON MRI.  HYPOECHOIC MASS, 8 X 6 X 4\u000a\u000aMM ON ULTRASOUND FOUND AT 5 O'CLOCK, 2 CM FROM NIPPLE.  CONSIDER IDC VS. OTHER.\u000a\u000a\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p138
ag78
aa(lp139
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a60 YO F  S/P MRI GUIDED BX OF LINEAR NON-MASSLIKE ENHANCEMENT IN THE UPPER OUTER\u000a\u000aLEFT BREAST - ? DCIS\u000a\u000a*PT S/P MR GUIDE CORE BX OF LINEAR NON-MASSLIKE ENHANCEMENT  UIQ LEFT BREAST =\u000a\u000aDCIS 2/12/14\u000a\u000a+ H/O RT BREAST LCIS/ ALH DX'D 2000.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p140
ag78
aa(lp141
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a64 YEAR OLD FEMALE WITH RIGHT BREAST MASS ?RADIAL SCAR VS. CANCER.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p142
ag78
aa(lp143
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a65 YEAR OLD FEMALE WITH HISTORY OF RIGHT MASTECTOMY WITH A CLUSTER OF SUSPICIOUS\u000a\u000aCALCIFICATIONS IN THE LEFT UPPER OUTER QUADRANT.  ? DCIS.  THE TARGETED CALCS\u000a\u000aARE CONFIRMED WITH RADIOGRAPH AND PLACED IN CASSETTE.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p144
ag78
aa(lp145
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a66 YO FEMALE WITH HISTORY OF LEFT BREAST SPINDLE CELL CARCINOMA.  PATIENT\u000a\u000aPRESENTS FOR U/S GUIDED BIOPSY OF ADDITIONAL SUBAREOLAR HYPOECHOIC MASS.  ?\u000a\u000aPAPILLOMA VS. FIBROADENOMA VS. OTHER.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p146
ag78
aa(lp147
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a69 YEAR OLD FEMALE WITH LEFT BREAST CALCIFICATIONS, ? DUCTAL CARCINOMA IN SITU.\u000a\u000aTARGETED CALCIFICATIONS ARE IN THE SPECIMEN.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p148
ag78
aa(lp149
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a69 YEAR OLD FEMALE WITH LEFT BREAST CALCIFICATIONS, ? DUCTAL CARCINOMA IN SITU.\u000a\u000aTARGETED CALCIFICATIONS ARE IN THE SPECIMEN.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p150
ag78
aa(lp151
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a74 YEAR OLD FEMALE WITH CALCIFICATIONS IN LOWER RIGHT BREAST, ? DCIS VS.\u000a\u000aSCLEROSING ADENOSIS.  CALCIFICATIONS ARE IN THE SPECIMEN.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p152
ag78
aa(lp153
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a83 YEAR OLD FEMALE WITH SEGMENTAL PLEOMORPHIC CALCIFICATIONS IN RIGHT BREAST, ?\u000a\u000aDUCTAL CARCINOMA IN-SITU.  TARGETED THE CALCIFICATIONS ARE IN THE SPECIMEN.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p154
ag78
aa(lp155
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a86 YEAR OLD FEMALE WITH HYPOECHOIC MASS IN THE RIGHT BREAST.  ? IDC.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p156
ag78
aa(lp157
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aBREAST LUMPS.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT 12 O'CLOCK, 0.7 CM NON-MASS ENHANCEMENT (S14-9160\u000a\u000a1A-D; 01/20/2014)\u000a\u000aB: BREAST CORE BIOPSY, RIGHT 12 O'CLOCK, 0.5 CM NON-MASS ENHANCEMENT (S14-9160\u000a\u000a2A-D; 01/20/2014)\u000a\u000a\u000a\u000aSLIDE-BLOCK DESCRIPTION:\u000a\u000aCONSULT MATERIALS RECEIVED FROM HARTFORD HOSPITAL, HARTFORD, CT\u000a\u000a\u000a\u000aA. BREAST CORE BIOPSY, LEFT 12 O'CLOCK, 0.7 CM NON-MASS ENHANCEMENT (S14-9160\u000a\u000a1A-D; 01/20/2014):\u000a\u000aSTAINED SLIDES: 12      UNSTAINED SLIDES: 0     BLOCKS: 0\u000a\u000a\u000a\u000aB. BREAST CORE BIOPSY, RIGHT 12 O'CLOCK, 0.5 CM NON-MASS ENHANCEMENT (S14-9160\u000a\u000a2A-D; 01/20/2014):\u000a\u000aSTAINED SLIDES: 12      UNSTAINED SLIDES: 0     BLOCKS: 0\u000a\u000a\u000a\u000a\u000a\u000a
p158
ag78
aa(lp159
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aCALCIFICATION IN THE LEFT BREAST IN A PATIENT WITH PRIOR HISTORY OF IDC/DCIS IN\u000a\u000a2006.  S/P SURGERY AND RADIATION THERAPY.  CALCIFICATIONS, EVALUATE FOR\u000a\u000aMALIGNANCY SINCE ORIGINAL CALCIFICATIONS HAD SIMILAR MORPHOLOGY.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p160
ag78
aa(lp161
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aCALCIFICATIONS IN THE LEFT BREAST\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p162
ag78
aa(lp163
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aKNOWN RIGHT BREAST GRADE 3 INVASIVE DUCTAL CARCINOMA, S/P BIOPSY OF UPPER OUTER\u000a\u000aBREAST CALCIFICATIONS ALSO ON RIGHT SIDE, SUSPECT DCIS\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p164
ag78
aa(lp165
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aLEFT BREAST HYPOECHOIC MASS V CYST, MEASURES 4 MM, AT 3 O'CLOCK, 3 CM FROM\u000a\u000aNIPPLE. HISTORY OF LEFT BREAST POORLY DIFFERENTIATED IDC, POST LUMPECTOMY WITH\u000a\u000aPOSITIVE MARGINS. DIFF: OIL CYST / FAT NECROSIS VS. FCC.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT 3:00 3 CM FROM NIPPLE\u000a\u000a\u000a\u000a
p166
ag78
aa(lp167
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aLEFT BREAST MASS AT 2:00, 3 CM FN - IRREGULAR, HYPOECHOIC, 3 X 3 X 4MM. ? RADIAL\u000a\u000aSCAR V. MALIGNANCY (IDC). POSITIVE H/O RIGHT BREAST CANCER.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT 2:00\u000a\u000a\u000a\u000a
p168
ag78
aa(lp169
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aTWO COLLECTIONS OF CALCIFICATIONS IN THE UPPER LEFT BREAST\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT, UPPER INFERIOR\u000a\u000aB: BREAST CORE BIOPSY, LEFT, UPPER SUPERIOR\u000a\u000a\u000a\u000a
p170
ag78
aa(lp171
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aPROCEDURES/ADDENDA\u000a\u000a\u000a\u000aHORMONE RECEPTOR QUANTITATION\u000a\u000aORDERED DATE: 11/10/2014\u000a\u000a\u000a\u000aA. BREAST CORE BIOPSY, RIGHT BREAST LOWER INNER:\u000a\u000aBLOCK TESTED:  A2\u000a\u000aTHE DUCTAL CARCINOMA IN-SITU TUMOR CELLS DO NOT STAIN FOR ESTROGEN RECEPTOR\u000a\u000aPROTEIN.\u000a\u000aTHE DUCTAL CARCINOMA IN-SITU TUMOR CELLS DO NOT STAIN FOR PROGESTERONE RECEPTOR\u000a\u000aPROTEIN.\u000a\u000a\u000a\u000aNOTE:\u000a\u000aESTROGEN AND PROGESTERONE RECEPTOR QUANTITATION: THE PERCENT OF IMMUNOREACTIVE\u000a\u000aNUCLEI IN THE TUMOR CELLS IS ASSESSED VISUALLY AND REPORTED AS FOLLOWS:\u000a\u000a- THE TUMOR CELLS STAIN (> 10% OF NUCLEI STAINED)\u000a\u000a- SOME TUMOR CELLS STAIN (1 TO <10% OF NUCLEI STAINED)\u000a\u000a- RARE TUMOR CELLS STAIN (< 1% OF NUCLEI STAINED)\u000a\u000a- THE TUMOR CELLS DO NOT STAIN (0% OF NUCLEI STAINED)\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  ATUL K BHAN MBBS, MD ON 11/10/2014 13:35***\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a53 YEAR OLD FEMALE WITH 2 GROUPS OF RIGHT BREAST CALCIFICATIONS. ? DCIS.\u000a\u000aSPECIMEN A: RIGHT LOWER INNER CALCIFICATIONS- TARGETED CALCS ARE PRESENT IN\u000a\u000aTRAY. SPECIMEN B: RIGHT UPPER OUTER CALCIFICATIONS- TARGETED CALCS ARE PRESENT\u000a\u000aIN TRAY.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT BREAST LOWER INNER\u000a\u000aB: BREAST CORE BIOPSY, RIGHT BREAST UPPER OUTER\u000a\u000a\u000a\u000a
p172
ag78
aa(lp173
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aPROCEDURES/ADDENDA\u000a\u000a\u000a\u000aHORMONE RECEPTOR QUANTITATION\u000a\u000aORDERED DATE: 11/10/2014\u000a\u000a\u000a\u000aA. BREAST CORE BIOPSY, RIGHT BREAST LOWER INNER:\u000a\u000aBLOCK TESTED:  A2\u000a\u000aTHE DUCTAL CARCINOMA IN-SITU TUMOR CELLS DO NOT STAIN FOR ESTROGEN RECEPTOR\u000a\u000aPROTEIN.\u000a\u000aTHE DUCTAL CARCINOMA IN-SITU TUMOR CELLS DO NOT STAIN FOR PROGESTERONE RECEPTOR\u000a\u000aPROTEIN.\u000a\u000a\u000a\u000aNOTE:\u000a\u000aESTROGEN AND PROGESTERONE RECEPTOR QUANTITATION: THE PERCENT OF IMMUNOREACTIVE\u000a\u000aNUCLEI IN THE TUMOR CELLS IS ASSESSED VISUALLY AND REPORTED AS FOLLOWS:\u000a\u000a- THE TUMOR CELLS STAIN (> 10% OF NUCLEI STAINED)\u000a\u000a- SOME TUMOR CELLS STAIN (1 TO <10% OF NUCLEI STAINED)\u000a\u000a- RARE TUMOR CELLS STAIN (< 1% OF NUCLEI STAINED)\u000a\u000a- THE TUMOR CELLS DO NOT STAIN (0% OF NUCLEI STAINED)\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  ATUL K BHAN MBBS, MD ON 11/10/2014 13:35***\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a53 YEAR OLD FEMALE WITH 2 GROUPS OF RIGHT BREAST CALCIFICATIONS. ? DCIS.\u000a\u000aSPECIMEN A: RIGHT LOWER INNER CALCIFICATIONS- TARGETED CALCS ARE PRESENT IN\u000a\u000aTRAY. SPECIMEN B: RIGHT UPPER OUTER CALCIFICATIONS- TARGETED CALCS ARE PRESENT\u000a\u000aIN TRAY.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT BREAST LOWER INNER\u000a\u000aB: BREAST CORE BIOPSY, RIGHT BREAST UPPER OUTER\u000a\u000a\u000a\u000a
p174
ag78
aa(lp175
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aPROCEDURES/ADDENDA\u000a\u000a\u000a\u000aHORMONE RECEPTOR QUANTITATION\u000a\u000aORDERED DATE: 2/4/2015\u000a\u000a\u000a\u000aA. BREAST CORE BIOPSY, RIGHT:\u000a\u000aBLOCK TESTED:  A1\u000a\u000aTHE DUCTAL CARCINOMA IN-SITU TUMOR CELLS STAIN FOR ESTROGEN RECEPTOR PROTEIN.\u000a\u000aTHE DUCTAL CARCINOMA IN-SITU TUMOR CELLS STAIN FOR PROGESTERONE RECEPTOR\u000a\u000aPROTEIN.\u000a\u000a\u000a\u000aNOTE:\u000a\u000aESTROGEN AND PROGESTERONE RECEPTOR QUANTITATION: THE PERCENT OF IMMUNOREACTIVE\u000a\u000aNUCLEI IN THE TUMOR CELLS IS ASSESSED VISUALLY AND REPORTED AS FOLLOWS:\u000a\u000a- THE TUMOR CELLS STAIN (> 10% OF NUCLEI STAINED)\u000a\u000a- SOME TUMOR CELLS STAIN (1 TO <10% OF NUCLEI STAINED)\u000a\u000a- RARE TUMOR CELLS STAIN (< 1% OF NUCLEI STAINED)\u000a\u000a- THE TUMOR CELLS DO NOT STAIN (0% OF NUCLEI STAINED)\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  ATUL K BHAN MBBS, MD ON 2/4/2015 11:03***\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a62 YO F WITH HYPOECHOIC MASS IN THE RIGHT BREAST.  IDC VS. ILC.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p176
ag78
aa(lp177
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000a\u000a\u000aPROCEDURES/ADDENDA\u000a\u000a\u000a\u000aHORMONE RECEPTOR QUANTITATION\u000a\u000aORDERED DATE: 8/26/2014\u000a\u000a\u000a\u000aA. LEFT BREAST CORE BIOPSY, MEDIAL:\u000a\u000aBLOCK TESTED:  A2\u000a\u000aTHE DUCTAL CARCINOMA IN-SITU TUMOR CELLS STAIN FOR ESTROGEN RECEPTOR PROTEIN.\u000a\u000aTHE DUCTAL CARCINOMA IN-SITU TUMOR CELLS STAIN FOR PROGESTERONE RECEPTOR\u000a\u000aPROTEIN.\u000a\u000a\u000a\u000aB. BREAST CORE BIOPSY, LEFT LATERAL:\u000a\u000aBLOCK TESTED:  B2\u000a\u000aTHE DUCTAL CARCINOMA IN-SITU TUMOR CELLS STAIN FOR ESTROGEN RECEPTOR PROTEIN.\u000a\u000aTHE DUCTAL CARCINOMA IN-SITU TUMOR CELLS STAIN FOR PROGESTERONE RECEPTOR\u000a\u000aPROTEIN.\u000a\u000a\u000a\u000aNOTE:\u000a\u000aESTROGEN AND PROGESTERONE RECEPTOR QUANTITATION: THE PERCENT OF IMMUNOREACTIVE\u000a\u000aNUCLEI IN THE TUMOR CELLS IS ASSESSED VISUALLY AND REPORTED AS FOLLOWS:\u000a\u000a- THE TUMOR CELLS STAIN (> 10% OF NUCLEI STAINED)\u000a\u000a- SOME TUMOR CELLS STAIN (1 TO <10% OF NUCLEI STAINED)\u000a\u000a- RARE TUMOR CELLS STAIN (< 1% OF NUCLEI STAINED)\u000a\u000a- THE TUMOR CELLS DO NOT STAIN (0% OF NUCLEI STAINED)\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  ATUL K BHAN MBBS, MD ON 8/26/2014 14:49***\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a71 YEAR OLD WOMAN, STATUS POST STEREOTACTIC CORE BIOPSY OF LEFT BREAST\u000a\u000aCALCIFICATIONS.  A. MEDIAL LEFT BREAST  PLEOMORPHIC SEGMENTAL CALCIFICATIONS;\u000a\u000a(TARGETED CALC'S IN X-RAYED SPECIMEN); ? DCIS.  B. LATERAL LEFT BREAST -\u000a\u000aCALCIFICATIONS - ? FIBROCYSTIC CHANGES; (TARGETED CALC'S IN X-RAYED SPECIMEN).\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT MEDIAL\u000a\u000aB: BREAST CORE BIOPSY, LEFT LATERAL\u000a\u000a\u000a\u000a
p178
ag78
aa(lp179
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a42 YEAR OLD FEMALE STATUS POST REDUCTION SURGERY WITH DCIS PRESENTING FOR BIOPSY\u000a\u000aOF LEFT BREAST MASS TO EVALUATE FOR ? INVASIVE CANCER VS. FIBROADENOMA.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p180
ag78
aa(lp181
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a46-YEAR-OLD FEMALE WITH NEW SUSPICIOUS CALCIFICATIONS IN HER LEFT UPPER OUTER\u000a\u000aBREAST. ? DCIS.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p182
ag78
aa(lp183
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a47 YEAR OLD FEMALE S/P MR-GUIDED BIOPSY OF NON MASS ENHANCEMENT IN THE ANTERIOR\u000a\u000aSUPERIOR LEFT BREAST. HX OF BIOPSY PROVEN IDC IN LEFT BREAST.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p184
ag78
aa(lp185
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a47 YEAR OLD FEMALE WITH INDETERMINATE RIGHT BREAST CALCIFICATIONS AT 12:00.\u000a\u000aPATIENT WAS DIAGNOSED WITH RIGHT IDC ON 4/29/15, NOW STATUS POST NEOADJUVANT\u000a\u000aCHEMOTHERAPY. SURGICAL TREATMENT PLANNED PENDING RESULTS OF THIS BIOPSY, DATE OF\u000a\u000aPLANNED SURGERY 11/3/15.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p186
ag78
aa(lp187
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a54YO F S/P STEREOTACTIC CORE BIOPSY OF CALCIFICATIONS IN THE LOWER OUTER\u000a\u000aQUADRANT OF LEFT BREAST.  THE CALCIFICATIONS ARE SEEN IN THE X-RAYED SPECIMEN IN\u000a\u000aTHE CASSETTE.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p188
ag78
aa(lp189
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a58 YEAR OLD FEMALE WITH A HISTORY OF GRADE 2 IDC IN THE LEFT BREAST ON\u000a\u000aNEOADJUVANT THERAPY PRESENTS FOR MRI GUIDED CORE BIOPSY OF 8 MM FOCAL NON-MASS\u000a\u000aENHANCEMENT IN THE UPPER INNER QUADRANT OF THE RIGHT BREAST\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p190
ag78
aa(lp191
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a68 YEAR OLD WITH DISTORTING MASS, 11:00 LEFT BREAST, 4 X 4 X 4 MM.  QUERY IDC VS\u000a\u000aRADIAL SCAR.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p192
ag78
aa(lp193
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a68 YEAR OLD WITH DISTORTING MASS, 11:00 LEFT BREAST, 4 X 4 X 4 MM.  QUERY IDC VS\u000a\u000aRADIAL SCAR.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p194
ag78
aa(lp195
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a77 YEAR OLD FEMALE PRESENTS FOR MRI GUIDED BIOPSY OF FOCAL NON MASS ENHANCEMENT\u000a\u000aIN THE LEFT BREAST AT 3 O'CLOCK.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT 3:00\u000a\u000a\u000a\u000a
p196
ag78
aa(lp197
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000a77 YO F WITH MASS IN THE SUBAREOLAR RIGHT BREAST. QUESTION PAPILLOMA VS CANCER.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT SUBAREOLAR\u000a\u000a\u000a\u000a
p198
ag78
aa(lp199
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aDDX: IDC, LYMPH NODE VS FAT NECROSIS. HISTORY OF LEFT BREAST GRADE 2 IDC AND\u000a\u000aDCIS STATUS POST LUMPECTOMY 9/2015. ENHANCING 6 MM FOCUS ON MRI.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p200
ag78
aa(lp201
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aFOCAL AREA OF NONMASS ENHANCEMENT IN THE RIGHT BREAST.  ? FCC VS PASH VS IDC.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT NONMASS ENHANCEMENT\u000a\u000a\u000a\u000a
p202
ag78
aa(lp203
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aINDETERMINATE LEFT BREAST CALCIFICATIONS. HISTORY OF RIGHT BREAST IDC DIAGNOSED\u000a\u000aIN 2015 STATUS POST NEOADJUVANT CHEMOTHERAPY AND MASTECTOMY IN 9/2015. RECENT\u000a\u000aSTEREOTACTIC BIOPSY OF ANOTHER GROUP OF CALCIFICATIONS IN THE LEFT BREAST\u000a\u000aDEMONSTRATED FEA.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p204
ag78
aa(lp205
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aPLEASE RUSH PATH RESULTS. S/P MR GUIDED BIOPSY OF 8MM NUMEROUS ENHANCEMENT IN\u000a\u000aTHE RIGHT BREAST-UPPER OUTER QUADRANT.  H/O CURRENT DIAGNOSIS OF ILC IN THE\u000a\u000aRIGHT BREAST.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p206
ag78
aa(lp207
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aPT PRESENT FOR STEREO GUIDED CORE BIOPSY OF PALPABLE FOCAL ASYMMETRY IN THE\u000a\u000aUPPER OUTER QUADRANT OF THE LEFT BREAST.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT, UPPER OUTER QUADRANT\u000a\u000a\u000a\u000a
p208
ag78
aa(lp209
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aPT PRESENT FOR STEREO GUIDED CORE BIOPSY OF PALPABLE FOCAL ASYMMETRY IN THE\u000a\u000aUPPER OUTER QUADRANT OF THE LEFT BREAST.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT, UPPER OUTER QUADRANT\u000a\u000a\u000a\u000a
p210
ag78
aa(lp211
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aRECENTLY DIAGNOSED LEFT BREAST DCIS.  TODAY, TWO GROUPS OF CALCIFICATIONS IN THE\u000a\u000aRIGHT UPPER OUTER BREAST WERE BIOPSIED:  A- MORE MEDIAL AND B- MORE LATERAL.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT CALCIFICATIONS, UPPER OUTER QUADRANT MORE MEDIAL\u000a\u000aGROUP\u000a\u000aB: BREAST CORE BIOPSY, RIGHT CALCIFICATIONS, UPPER OUTER MORE LATERAL GROUP\u000a\u000a\u000a\u000a
p212
ag78
aa(lp213
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aS/P STEREOTACTIC BIOPSY OF INDETERMINATE CALCIFICATION WITH ASSOCIATED\u000a\u000aARCHITECTURAL DISTORTION IN THE RIGHT BREAST AT 9 O'CLOCK. THE CALCIFICATIONS\u000a\u000aARE PRESENT IN THE CASSETTE. DDX: BREAST MALIGNANCY VERSUS RADIAL SCAR.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p214
ag78
aa(lp215
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aS/P STEREOTACTIC BIOPSY OF INDETERMINATE CALCIFICATION WITH ASSOCIATED\u000a\u000aARCHITECTURAL DISTORTION IN THE RIGHT BREAST AT 9 O'CLOCK. THE CALCIFICATIONS\u000a\u000aARE PRESENT IN THE CASSETTE. DDX: BREAST MALIGNANCY VERSUS RADIAL SCAR.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000a\u000a\u000a
p216
ag78
aa(lp217
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aSTATUS POST STEREOTACTIC CORE BIOPSY OF LEFT BREAST CALCIFICATIONS IN THE UPPER\u000a\u000aOUTER QUADRANT. THE CALCIFICATIONS ARE PRESENT IN THE CASETTE. DDX: DCIS VS FCC.\u000a\u000a\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, LEFT\u000a\u000a\u000a\u000a
p218
ag78
aa(lp219
VFINAL DIAGNOSIS\u000a\u000aCERTIFIES THAT HE/SHE HAS PERSONALLY REVIEWED THIS CASE AND CONFIRMED OR\u000a\u000aCORRECTED THE DIAGNOSIS.\u000a\u000a\u000a\u000aPROCEDURES/ADDENDA\u000a\u000a\u000a\u000aHORMONE RECEPTOR QUANTITATION\u000a\u000aORDERED DATE: 11/20/2015\u000a\u000a\u000a\u000aB. RIGHT AXILLARY LYMPH NODE CORE BIOPSY:\u000a\u000aBLOCK TESTED:  B1\u000a\u000aTHE METASTATIC TUMOR CELLS STAIN FOR ESTROGEN RECEPTOR PROTEIN.\u000a\u000aTHE METASTATIC TUMOR CELLS STAIN FOR PROGESTERONE RECEPTOR PROTEIN.\u000a\u000aTHE METASTATIC TUMOR CELLS DO NOT SHOW OVEREXPRESSION OF HER-2 PROTEIN.\u000a\u000a\u000a\u000aNOTE:\u000a\u000aESTROGEN AND PROGESTERONE RECEPTOR QUANTITATION: THE PERCENT OF IMMUNOREACTIVE\u000a\u000aNUCLEI IN THE TUMOR CELLS IS ASSESSED VISUALLY AND REPORTED AS FOLLOWS:\u000a\u000a- THE TUMOR CELLS STAIN (> 10% OF NUCLEI STAINED)\u000a\u000a- SOME TUMOR CELLS STAIN (1 TO <10% OF NUCLEI STAINED)\u000a\u000a- RARE TUMOR CELLS STAIN (< 1% OF NUCLEI STAINED)\u000a\u000a- THE TUMOR CELLS DO NOT STAIN (0% OF NUCLEI STAINED)\u000a\u000a\u000a\u000aHER-2 QUANTITATION: THE TUMOR CELLS MEMBRANE IMMUNOREACTIVITY IS EVALUATED\u000a\u000aVISUALLY AND REPORTED AS FOLLOWS:\u000a\u000a- DO NOT SHOW OVEREXPRESSION (0 TO 1+, NO/MINIMAL IMMUNOREACTIVITY OR\u000a\u000aINCOMPLETE MEMBRANE STAINING OF TUMOR CELLS)\u000a\u000a- SHOW MODERATE (2+) OVEREXPRESSION (WEAK TO MODERATE COMPLETE OR INCOMPLETE\u000a\u000aMEMBRANE IMMUNOREACTIVITY IN > 10% OF TUMOR CELLS)\u000a\u000a- SHOW STRONG (3+) OVEREXPRESSION (STRONG COMPLETE MEMBRANE IMMUNOREACTIVITY\u000a\u000aIN > 10% OF TUMOR CELLS)\u000a\u000a\u000a\u000aREFERENCE:  ASCO/CAP HER2 TESTING GUIDELINE UPDATE, ARCH PATHOL LAB MED.\u000a\u000aDOI:10.5858/ARPA.2013-0953.SA\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  ATUL K BHAN MBBS, MD ON 11/20/2015 10:11***\u000a\u000a\u000a\u000aADDENDUM\u000a\u000aORDERED DATE: 11/20/2015\u000a\u000a\u000a\u000aADDENDUM NOTE:  THIS ADDENDUM IS ADDED TO DOCUMENT RESULTS OF\u000a\u000aIMMUNOHISTOCHEMICAL STAINS PERFORMED ON PART A.  THESE INCLUDE MYOSIN AND P63\u000a\u000aWHICH BOTH SHOW POSITIVE STAINING FOR MYOEPITHELIAL CELLS, SUPPORTING THE\u000a\u000aDIAGNOSIS REPORTED ABOVE.\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  KRISTINA M BRAATEN MD ON 11/20/2015 16:50***\u000a\u000a\u000a\u000aHER-2 FISH QUANTITATION ANALYSIS\u000a\u000aORDERED DATE: 11/24/2015\u000a\u000a\u000a\u000aB. RIGHT AXILLARY LYMPH NODE CORE BIOPSY:\u000a\u000aBLOCK TESTED:  B1\u000a\u000aHER-2/NEU GENE IN TUMOR CELLS: 1.0 (NOT AMPLIFIED).\u000a\u000a\u000a\u000aNOTE:  A RATIO OF GREATER THAN 2.0 OR EQUAL TO 2.0 INDICATES HER-2/NEU GENE\u000a\u000aAMPLIFICATION.\u000a\u000a\u000a\u000aRESULTS ARE EXPRESSED AS THE AVERAGE RATIO OF HER-2 SIGNALS TO CHROMOSOME 17\u000a\u000a(CEP17) SIGNALS IN 30 TUMOR CELL NUCLEI USING PATHVYSION BY HER-2 DNA PROBE KIT\u000a\u000a(ABBOTT MOLECULAR INC.). THE AVERAGE HER-2 COPY NUMBER/CELL IS 1.5 AND THE\u000a\u000aAVERAGE CEP17 COPY NUMBER/CELL IS 1.5.\u000a\u000a\u000a\u000aRESULTS NEAR THE CUTOFF POINT (HER-2/CEP17 RATIO 2.0) SHOULD BE INTERPRETED WITH\u000a\u000aCAUTION IF THE HER-2/CEP17 RATIO IS < 2 WITH THE AVERAGE HER-2 COPY NUMBER EQUAL\u000a\u000aTO OR GREATER THAN 4 AND < 6.0 SIGNALS PER CELL (EQUIVOCAL AMPLIFICATION).\u000a\u000a\u000a\u000aREFERENCE: ASCO/CAP HER2 TESTING GUIDELINE UPDATE, ARCH PATHOL LAB MED.\u000a\u000aDOI:10.5858/ARPA.2013-0953.SA\u000a\u000a\u000a\u000a\u000a\u000a\u000a\u000a***ELECTRONICALLY SIGNED OUT BY:  ATUL K BHAN MBBS, MD ON 11/24/2015 15:17***\u000a\u000a\u000a\u000aCLINICAL HISTORY\u000a\u000aSTATUS POST U/S GUIDED BIOPSY OF RIGHT BREAST MASS AND RIGHT AXILLARY NODE:\u000a\u000aSPECIMEN A) RIGHT BREAST MASS AT 10 O'CLOCK, 6CM FN; ?BREAST MALIGNANCY.  B)\u000a\u000aRIGHT AXILLARY LYMPH NODE WITH THICKENED CORTEX; ? BREAST CARCINOMA METS VS\u000a\u000aREACTIVE.\u000a\u000a\u000a\u000aSPECIMENS SUBMITTED:\u000a\u000aA: BREAST CORE BIOPSY, RIGHT\u000a\u000aB: LYMPH NODE CORE BIOPSY, RIGHT AXILLARY\u000a\u000a\u000a\u000a
p220
ag78
aa.